Review of Active Extracorporeal Medical Devices to Counteract Freezing of Gait in Patients with Parkinson Disease

Mónica Huerta, Boris Barzallo, Catalina Punin, Andrea Garcia-Cedeño, Roger Clotet

Resultado de la investigación: Contribución a una revistaCríticarevisión exhaustiva

Resumen

Parkinson Disease (PD) primarily affects older adults. It is the second-most common neurodegenerative disease after Alzheimer’s disease. Currently, more than 10 million people suffer from PD, and this number is expected to grow, considering the increasing global longevity. Freezing of Gait (FoG) is a symptom present in approximately 80% of advanced-stage PD’s patients. FoG episodes alter the continuity of gait, and may be the cause of falls that can lead to injuries and even death. The recent advances in the development of hardware and software systems for the monitoring, stimulus, or rehabilitation of patients with FoG has been of great interest to researchers because detection and minimization of the duration of FoG events is an important factor in improving the quality of life. This article presents a review of the research on non-invasive medical devices for FoG, focusing on the acquisition, processing, and stimulation approaches used.

Idioma originalInglés
Número de artículo976
PublicaciónHealthcare (Switzerland)
Volumen10
N.º6
DOI
EstadoPublicada - jun. 2022

Nota bibliográfica

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Huella

Profundice en los temas de investigación de 'Review of Active Extracorporeal Medical Devices to Counteract Freezing of Gait in Patients with Parkinson Disease'. En conjunto forman una huella única.

Citar esto